Luana M S Marins
Overview
Explore the profile of Luana M S Marins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
da Silva R, Marins L, Guaraldo L, Luz P, Cardoso S, Moreira R, et al.
AIDS Res Ther
. 2023 Aug;
20(1):57.
PMID: 37605195
Background: The increased survival provided by the access, development, and evolution of antiretroviral drugs (ARV) greatly increased the life expectancy of people living with HIV (PWH). This has also led...
2.
Torres T, Luz P, Bezerra D, Almeida-Brasil C, Marins L, Veloso V, et al.
Psychol Health Med
. 2021 Jul;
26(sup1):20-36.
PMID: 34219572
Internalized homonegativity results from the acceptance of negative attitudes about one's same-sex orientation, which has negative consequences for the health of gay, bisexual and other men who have sex with...
3.
Torres T, Luz P, Marins L, Bezerra D, Almeida-Brasil C, Veloso V, et al.
Health Qual Life Outcomes
. 2021 Apr;
19(1):117.
PMID: 33836775
Background: Valid and reliable instruments are needed to measure the multiple dimensions of perceived risk. The Perceived Risk of HIV Scale is an 8-item measure that assesses how people think...
4.
Luz P, Torres T, Almeida-Brasil C, Marins L, Bezerra D, Veloso V, et al.
Health Qual Life Outcomes
. 2020 Oct;
18(1):322.
PMID: 33008400
Background: HIV-related stigma, or the degree to which people living with HIV endorse negative stereotypes associated with HIV, is associated with poor continuum of care outcomes. We translated the 12-item...
5.
Luz P, Torres T, Almeida-Brasil C, Marins L, Veloso V, Grinsztejn B, et al.
AIDS Behav
. 2020 Sep;
25(3):748-757.
PMID: 32940826
In Brazil, pre-exposure prophylaxis (PrEP) is currently available for gay, bisexual, and other men who have sex with men. As PrEP use depends on an individual's perceived risk, we explored...
6.
Torres T, Marins L, Veloso V, Grinsztejn B, Luz P
BMC Infect Dis
. 2019 Dec;
19(1):1067.
PMID: 31856746
Background: Brazil has the largest population of individuals living with HIV/AIDS in Latin America, with a disproportional prevalence of infection among gays, bisexuals and other men who have sex with...
7.
Marins L, Torres T, Leite I, Moreira R, Luz P, Hoagland B, et al.
PLoS One
. 2019 Aug;
14(8):e0221281.
PMID: 31430318
Introduction: Efficacy of daily emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) for PrEP is strongly dependent on the adherence. We examined the concordance between indirect adherence measures and protective drug levels among participants...
8.
Hoagland B, Moreira R, De Boni R, Kallas E, Valdez Madruga J, Vasconcelos R, et al.
J Int AIDS Soc
. 2017 Apr;
20(1):21472.
PMID: 28418232
Introduction: The efficacy of pre-exposure prophylaxis (PrEP) in preventing sexual acquisition of human immunodeficiency virus (HIV) is well established. Little is known about the feasibility of PrEP implementation in middle-income...
9.
Abreu P, Castro H, Paes-de-Carvalho R, Rodrigues C, Giongo V, Paixao I, et al.
Chem Biol Drug Des
. 2012 Sep;
81(2):185-97.
PMID: 22985449
Recently, many efforts have been made to develop N-methyl-D-aspartic acid receptor antagonists for treating different pathological conditions such as thrombo-embolic stroke, traumatic head injury, Huntington's, Parkinson's, and Alzheimer's diseases). However,...